We examined the biological effect of krill phosphatidylserine (K-PS) on brain ageing and investigated the mechanisms that how K-PS works on the brain using senescence-accelerated mouse (SAM) model with age-associated neurodegeneration. SAMP10 mice with 5 months of age were treated orally once a day for 75 days with 10 or 100 mg kg −1 d −1 K-PS (low and high dose). The effect of K-PS treatment on the cross-sectional area and Nissl body number of the neocortex at point C, an area prone to atrophy in SAMP10 mice, behavior and oxidative stress were evaluated by Image-Pro Plus software, step-down testing, and malondialdehyde (MDA) and glutathione peroxidase (GSH-Px) assays. Ionized calcium binding adaptor molecule 1 (Iba-1) and insulin-like growth factor 1 (IGF-1) expression was evaluated using immunohistochemistry. Low or high doses of K-PS significantly increased the cross-sectional area and Nissl body number at point C, partly reversed memory impairment, increased the activity of GSH-Px and reduced MDA levels. Moreover, immunohistochemistry indicated that K-PS suppressed Iba-1 expression and upregulate the expression of IGF-1. These findings suggest that K-PS could prevent or slow the progression of brain atrophy and neuronal damage associated with aging by the inhibition of Iba-1 and the upregulation of IGF-1 expression.
Introduction
Ageing, which is characterized by extensive degeneration in terms of morphology and function in the brain tissue, has been an important risk factor for the kinds of neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (Stern et al., 1987; Prasad & Aggarwal, 2011) . With older age, there is loss of neuronal cells in neocortical, hippocampal, and cerebellar areas, shrinkage of neurons, leading to compromised neuronal integrity and reduction in synaptic density (Simić et al., 1997; Morrison & Hof, 2007) . Consequently, age is believed to increase risk for AD because it is independently linked to brain atrophy (Raz et al., 2004) .
Brain tissue atrophy means the reduction of neurons and the loss of neuron-neuron connections. Atrophy generates either widespread, which means a shrunk of whole brain tissue; or locally which means a damage of limited region of the brain.
Phosphatidylserine (PS) is a member of natural phospholipids and an essential cell membrane building-block. It has been known that PS is one of the important brain phospholipids and plays a key role in maintaining the structure and function of normal neurons. PS and other essential fatty acids especially the docosahexaenoic acid (DHA), may also play an important role in many functions of neuron membranes, such as release of neurotransmitters, signal transduction, cell's communication, cell growth and apoptosis (Vance & Steenbergen, 2005) . On the other hand, the report about association between ageing and alterations in brain lipid composition (Svennerholm et al., 1991) , suggested that phospholipids, as the fundamental components of neuronal membranes, may serve as effective treatment for cognitive deterioration.
The first generation PS material was the PS extracted from bovine cortex (BC-PS). Administration of BC-PS to patients suffered from age-associated memory damage could significantly improve the performance of attention, learning and memory (Crook et al., 1991) . Lots of other studies have also shown that treatment with PS can counteract the pathological dysfunctions in patients with age-related disorders and improve the ability of memory and learning in rats (Corwin et al., 1985; Delwaide et al., 1986; Zanotti et al., 1986; Amaducci, 1988) . However, to avoid the possibility of the contamination by protein prions of bovine spongiform encephalopathy (BSE), BC-PS was limited in use, and more safety alternative material was needed. As the second generation PS, soybean PS (SB-PS) was developed by phospholipase D-catalyzed transphosphatidylation of soybean phosphatidylcholine (also known as soy lecithin). However, there still lack of evidence to support this use.
Surely, preliminary studies in rats indicate that SB-PS may have comparable effects on cognition when compared with BC-PS (Blokland et al., 1999) . But, later clinical trials proved that a daily administration of SB-PS does not change memory or other cognitive functions in older patients with memory dysfunction (Jorissen et al., 2001) . In fact, the fatty acids attached to the phospholipids in the SB-PS are not identical to those in the BC-PS, because the high unsaturated fatty acids (HUFA), especially DHA hardly existing in fatty acid of soybean. It is surmised that this fault caused that above-mentioned results were not consistent. Therefore, development of a new safety and powerful PS material is expected.
Recently, the marine PS which extracted from marine life, such as krill, squid and fish, was expected to become the third generation of PS, and has been regarded as a hopeful alternative of BS-PS because of the substantial amount of omega-3 HUFA, especially DHA and eicosapentaenoic acid (EPA) in a phospholipid form. A recent study showed that krill PS (K-PS), which transphophatidylated from krill phosphatidylcholine (K-PC), ameliorated the spatial memory ability and protected against cholinergic cell injure in aged rats (Lee et al., 2010) . In a double-blind placebo-controlled trial, the result indicated that supplementation of 300 mg/day PS-DHA for 15 weeks may recover the degenerative memory in elderly without dementia (Vakhapova et al., 2010) .
The senescence-accelerated mouse (SAM) has been well documented in the historical development of animal models of ageing (Shimada et al., 1992 (Shimada et al., & 2003 . A lot of studies by SAM model have been conducted in different region of ageing science, and SAMP10 mice, as a distinctive model of age-related, inherited cerebral atrophy with cognitive dysfunction, have been reviewed extensively (Shimada, 1999) . Although there is evidence that K-PS produce neuroprotective activity, no detailed and further study of its effect on neurodegeneration using SAMP10 mice has been reported to date to our knowledge. In the study reported here, SAMP10 mice were selected as a model of neurodegeneratipn to explore whether treatment with K-PS can reduce neuronal damage and behavioral deficits, and to investigate the mechanisms by which K-PS affects the brain.
Materials and Methods

Mice
Five-month-old of male SAMP10 and SAMR1 strains of mice were purchased from the First Teaching Hospital of Tianjin University of Traditional Chinese Medicine (SCXK2008-0001, No.0001375, Tianjin, China). The mice were kept in a room under a controlled temperature of 23 ± 2°C, humidity of 50 ± 10% and a 12-hour light-dark cycle during study periods. Certified commercial rodent diet (Beijing Hua Fu Kang Laboratories) and sterile water were provided ad libitum. The SAMP10 mouse was used as a model of age-related cerebral degeneration, while the SAMR1 mouse was used as a control strain for normal ageing. 
Step-down Test
A step-down passive avoidance computer-aided controlling system (YLS-3TB, Gene&I, Beijing, China) was conducted to show the changes between SAMP10 and SAMR1 groups in their learning and memory. The equipment and test procedure were similar to those described by Shuchang et al. (2008) . All mice were tested using a step-down test in a passive avoidance acrylic chamber. The unit consisted of copper rods and a well-insulated 4 cm × 4 cm × 5 cm platform made of rubber in one corner of the chamber. The mice were placed in the chamber for a 3-minute adaptation period and then placed the mice on the platform. Their latency to step down on the grid with all four paws was measured. Once the mice stepped down on the copper bars, they would receive a 0.2-mA scrambled foot shock. The animals showed an instinctive reaction to jump back onto the platform to avoid the electric shock. Mice were tested in this manner for 5 minutes. The number of times that the mice stepped down from the platform within the 5-minute period was recorded as acquisition errors. Twenty-four hours later, this same procedure was repeated, and the step-down meaning of latency time was used as a measure of memory retention. The number of times that the mice stepped down onto the platform within the 5-minute interval was recorded as retention errors. All behavioral testing procedures were conducted in a blinded environment.
Evaluation of GSH-Px and MDA
Four to six mice were used for each group. Brains were rapidly moved into ice-cold phosphate buffered saline (PBS) and scraped in lysis buffer. The insoluble material was centrifuged at 12,000 rpm for 20 min and the supernatants were used for the determination of GSH-Px activities and MDA levels. GSH-Px activity was measured by the method of Lawrence and Burk (Lawrence & Burk, 1976) with modifications. The absorbance was recorded at 340 nm, immediately and then every 30 sec over a period of 3 min, using a Spectronic-20 spectrophotometer. GSH-Px activity was expressed as micro-unit per mg of fresh weight. Level of lipid peroxidation was expressed as the content of malondialdehyde (MDA) according to Zhang et al. (2005) . The procedure was conducted with MDA commercial kits according to the manufacturer's instructions. The absorbance of the supernatant was recorded at 532 nm (450 nm was used as the reference wavelength). Lipid peroxidation was expressed as the MDA content in μM per mg of fresh weight.
Immunohistochemistry
To demonstrate the expression and localization of ionized calcium binding adaptor molecule 1 (Iba-1) and insulin-like growth factor 1 (IGF-1), immunohistochemistry was used as described previously. Coronal sections were deparaffinized with xylene and a series of graded alcohol solutions. Then, phosphate buffered saline solution (PBS) was used to wash the section.).Treated with citrate buffered solution, digested with 10 μg/ml proteinase K-based solution, then blocked with 50 μl normal goat serum, and reacted with anti-Iba-1 (1:100) and anti-IGF-1 (1:100) overnight at 4°C. Then washed off the primary antibodies and incubated with the corresponding secondary antibodies for 2 h at 37°C, stained with 3,3′-diaminobenzidine (DAB), dehydrated with graded alcohol solution and mounted with triglyceride, visualized with a microscope (Eclipse50i, Nikon).
Statistical Analysis
All results were represented as the mean ± standard deviation (SD). SPSS (SPSS Inc., Chicago, IL, USA) were used for further statistical analysis. Data were analyzed by one-way analysis of variance (ANOVA) when comparing mice in the same strain or by two-way ANOVA when comparing mice between different strains of corresponding age. Tukey's procedure was used for all post hoc tests.
Results
K-PS Increased the Cortical Cross-sectional Area of Point C in SAMP10 Mice
As shown in Figure 1A , black line circled up the measured cortical cross-sectional area of point C in SAM mice of each group. The bar graph of Figure 1B shows the effect of K-PS on the cortical cross-sectional area at point C. Compared with the group of baseline P10 mice and R1 mice, the cortical cross-sectional area at point C in P10 mice had a 10.9% and 8.26% loss to a level of 9.4 ± 0.688 mm 2 (P < 0.01 and P < 0.05). In contrast, the cortical cross-sectional area at point C in mice treated with K-PS low showed a significant increase to a level of 10.29 ± 0.52 mm 2 compared with the P10 mice (P < 0.05). Figure 1C shows the location of point C. Localization of atrophy-prone landmark pointed at a dorsal view of the brain in the photo image [1] . (C) Bar graphs show area changes in cross-sectional area of the neocortex in Plane C. Data expressed as mean ± SD for 4-5 mice in each group. ▲▲ P < 0.01 compared to the same month age in the SAMR1 strain. # P < 0.05 compared to the previous month age in the same strain. * P < 0.05 compared to the P10.
K-PS Increased the Nissl Body Number at Point C in SAMP10 Mice
For the Nissl body count, we used thionien staining as described previously to observe changes at the cross-sectional area of the neocortex at point C. In baseline SAM mice and SAMR1 mice, the closely arranged neuron morphology was intact, and deep blue staining of lumpy or granular Nissl bodies could be seen in the neuronal cytoplasm. In P10 mice, Nissl bodies partially or entirely dissolved or disappeared and the neurons, with broken morphology, were arranged loosely. The number of deep blue staining of lumpy or granular in the K-PS low and K-PS high groups was significantly greater than the P10 group ( Figure 2A ). As Figure 2B shows, the number of Nissl bodies in the P10 group declined to 33.83 ± 7.6 per high power field, with a 36.7% loss (P < 0.01) compared with the baseline P10 group and a 32.3% loss (P < 0.01) compared with the R1 group. Conversely, the number of Nissl bodies in mice dosed with K-PS low and K-PS high was significantly higher than in the mice in group P10 (P = 0.04 and P = 0.03 respectively). In baseline SAM mice and SAMR1 mice, closely arranged neuron morphology was intact, and deep blue staining of lumpy or granular Nissl bodies could be seen in the neuronal cytoplasm. In P10 mice, Nissl bodies partially or entirely dissolved or disappeared and the neurons, with broken morphology, were arranged loosely. The deep blue staining of lumpy or granular Nissl bodies of neurons in the groups dosed with K-PS showed a significant increase compared with the P10 mice. (B) Bar graphs showed the count of Nissl bodies in the cross-section of the neocortex in Plane C in each group. ▲▲ P < 0.01 compared to the same month-age in the SAMR1 strain. ## P < 0.01 compared to the previous age in months in the same strain. * P < 0.05 compared to the P10 mice. Scale bar = 100 μm.
K-PS Improved Memory in SAMP10 Mice
To determine the effect of K-PS on the ability to remember in SAM mice, we examined passive avoidance behavior using the step-down test. We observed that for memory, no remarkable difference was found in latency between the two strains of mice in the baseline groups. Compared with the baseline P10 mice and R1 mice, the latency of mice in group P10 was markedly shortened to 16.2 ± 3.37 sec (P < 0.01). The latency of SAMP10 mice in the K-PS low treated group was longer, with a remarkable increase compared with the mice in the P10 group (P < 0.05) ( Figure 3A ). In terms of error, the mice in group P10 showed a greater tendency to err compared with mice in the baseline P10 group (P = 0.1). Although the difference in error times was not statistically significant, K-PS appeared to reduce the tendency of error in P10 mice ( Figure 3B ). for 75 days had a significantly longer latency compared to the P10 mice. (B) Changes in error times in SAMP10 mice. ▲▲ P < 0.01 compared to the same month age in the SAMR1 strain. ## P < 0.01 compared to the previous month age in the same strain. * P < 0.05 compared to the P10.
K-PS Increased GSH-Px Activities and Decreased MDA Content in SAMP10 Mice
To establish the degree of oxidative stress in brain tissue, we examined GSH-Px activities and MDA levels in SAM mice. As Figure 4A showed, a significant difference in GSH-Px activities was found between the baseline P10, R1 and P10 groups (P < 0.01). Compared with the P10 group, a low or high dose of K-PS increased GSH-Px activities in SAMP10 mice markedly in a dose-dependent manner (P < 0.01 or P < 0.001). MDA concentrations in SAM mice are presented in Figure 4B . Compared with the mice in the baseline P10 group, MDA levels in the K-PS dosed groups deceased remarkably (P < 0.01 or P < 0.001). mice showed an increase in MDA concentrations compared with the controls. Both doses of K-PS deceased MDA concentrations in SAMP10 mice markedly. Data expressed as mean ± SD for 4-6 mice in each group. ▲▲▲ P < 0.001 compared to the same month age in the SAMR1 strain. ### P < 0.001 compared to the previous age in months in the same strain, ** P < 0.01, *** P < 0.001 compared to the P10. 
K-PS Downregulated Iba-1 Expression and Upregulated IGF-1 Expression in SAMP10 Mice
Immunohistochemistry using Iba-1 antibodies showed an increase in immunoreactivity in P10 mice compared with baseline P10 mice and R1 mice, which indicated a strong microglial activity. The staining of Iba-1 was restricted within cytoplasm and stained as a brown dot. We found decreased expression of positive staining as detected by Iba-1 antibody in the cross-sectional area of the neocortex at point C in K-PS high dosed mice compared to P10 mice ( Figure 5 ). As shown in Figure 6 , immunoreactivity of IGF-1 in P10 mice was remarkably downregulated compared with the baseline P10 and R1 groups. Compared with the P10 mice, the immunoreactivity of IGF-1 in K-PS low dosed mice was significantly increased. 
Discussion
In the present study, we analyzed the anti-ageing effect of oral administration of K-PS. The results of this study showed an anti-ageing effect of K-PS on SAMP10 mice, reflected in less cortical atrophy, improved neurocognitive function, and suppression of Iba-1 expression as well as upregulation of IGF-1 expression. The SAMP10 strain of mice with age-related cerebral atrophy has been regarded as a model of age-associated neurodegeneration (Shimada et al., 2006) . SAMP10 mice also experience an age-related loss of synapses and age-related dendritic retractions in prefrontal neurons. Atrophy is most exhibited at the anterior part of the cerebral cortex and olfactory structures. In this study, we examined the effect of K-PS on the cross-sectional area and Nissl body number in the frontal brain, the most prominent atrophy area. The cortical cross-sectional area in P10 mice was lower than that in R1 or baseline P10 mice during breeding. K-PS treatment with doses of 10 or 100 mg kg −1 d −1 increased the cortical cross-sectional area in SAMP10 mice, showing a similar effect to that on the number of Nissl bodies. The administration of a low or high dose of K-PS appears to improve the number of Nissl bodies indicating a recovery in neurons.
More and more evidence suggests that omega-3 HUFAs maintain and enhance the functions of the central nervous system (CNS), including learning and memory. The formation of newly-generated neurons in the hippocampus is associated with learn and memory abilities (Song et al., 2002; Schmidt-Hieber et al., 2004) . When subjected to DHA chronically, both the young and aged rats' learning ability is improved (Gamoh et al., 1999; . In addition, the neurogenesis of the granule cell layer in rats can be promoted by DHA (Kawakita et al., 2006) . Furthermore, the dietary intake of both DHA-rich egg phospholipids and tuna oil can increase the maximum acetylcholine release from the hippocampus in the rats by increasing the DHA content. Evidence also indicates that EPA treatment can reduce the impairment of memory function from ageing (Okabe et al., 2011; Sinn et al., 2011) . A longer latency was found in SAMP10 mice with low doses of K-PS, which suggests that accelerated senescence can be suppressed by the administration of K-PS.
Recently, oxidative stress has been regarded as an important causal factor of senescence (Toru et al., 2010) . The components of K-PS (DHA or EPA) have been found to have antioxidative effects on cells and animals (Jensen et al., 2009; Kim et al., 2007; Pan et al., 2009) . As an important lipid peroxidation product, MDA can be considered as an indicator for the oxidative damage extend. Abnormal alteration of MDA content is related to memory impairment, as reported in previous studies (Um et al., 2006) . GSH is a sensitive indicator of the ability of a cell or tissue to resist damage. When oxygen free radicals increase, cells and tissues need more nicotinamide adenine dinucleotide phosphate (NADP) to be recovered from the glutathione cycle, where glutathione is reduced to GSH. The damaged GSH system may cause oxidative stress and destruction of the nigrostriatal pathway as well as rendering the pathway susceptible to a toxic insult (Jha et al., 2000) . Our results show that the SAMP10 mice suffered from oxidative stress more than SAMR1 mice due to the inherited cerebral atrophy, both low and high doses of K-PS can increase GSH-Px activity and decrease MDA levels significantly. This suggests that K-PS treatment offers antioxidant benefits. As oxidative stress within mitochondria has been regarded as a major risk factor of ageing (Romano et al., 2010) , we assume that the antioxidative properties of K-PS may play a role in this anti-ageing effect on SAMP10 mice.
Microglial cells are involved in infection, hypoxic-ischemic brain injury disease and degenerative diseases of the nervous system in the pathogenesis (Moon et al., 2009; Wang et al., 2011) . According to the former studies about microglial cells morphology in age-related disease, researchers have observed that microglia become activated in aged rats (Ogura et al., 1994; Kawamata et al., 1998) . Quantitative analysis has shown that abnormalities of microglia in the early stage may cause the SAMP10 mice vulnerable to age-related neuronal degeneration (Hasegawa-Ishii et al., 2011) . Iba-1, a marker of microglial activation (Ahmed et al., 2007) , was evaluated in this paper; the results showed that K-PS low significantly downregulated the expression of Iba-1 which indicated that activated microglial cells were inhibited to a certain extent. A previous study indicated that hydrogen peroxide originated from the dismutation of superoxide produced by nicotinamide adenine dinucleotide phosphate (NADPH) oxidase may regulate the microglial cells change (Mander et al., 2006) . NADPH oxidase is the source of reactive oxygen species (ROS) generated by activated microglial cells (Hosokawa 2002; Chiba et al., 2005) . Thus, we assume that the inhibitory effect of K-PS on microglial cells may be related to the antioxidant effect on SAMP10 mice as discussed above. the loss of IGF which is necessary for learning and memory may cause cognitive disabilities (Lupien et al., 2003) . The molecular mechanisms of signaling via cross-talk between IGF-1 and ROS-mediated redox signaling pathways may play an important role in regulation of ageing and longevity (John, 2009) . Consequently, the improvement in memory and the antioxidant effect may be partially due to the upregulation of IGF-1 by K-PS. KPS contained 11.3% EPA and 5.6% DHA. The high dose had 10-times more EPA or DHA than those of the low dose. Based on the above results, we can see that low dose had almost the same effect with the high dose on the mice and show no dose-dependent effect. A few factors that may have contributed to our detecting of no significant difference between low and high dose include the following: (1) Low dose of K-PS may basically occupy the role of targets and show a saturated pharmacological effects so that high dose of K-PS can't play better the pharmacological effects. (2) It is important to note that the efficacy of K-PS is partly due to the multi-component, which allows for a comprehensive regulatory effect. Compared with single-component receptor drugs, each component in K-PS plays a different role in the overall pharmacological action, which makes it more difficult to define the dose-effect relationship. (3) High dose of PS may generate pharmacological effects other than what we have done. Taken together, we plan to consider a more sensitive dose evaluation of K-PS to reveal a benefit of anti-brain ageing effect in future studies.
Conclusion
Taken together, our findings suggest that a 10 or 100 mg kg −1 d −1 dose of K-PS may reduce oxidative damage and subsequent cortical atrophy as well as Nissl body loss, resulting in improved memory ability. These protective effects may be due to K-PS's inhibition of microglial activation and upregulation of IGF-1. Thus, K-PS may be useful in preventing or slowing progression of cortical atrophy and neuronal damage induced by ageing, and K-PS may become an important source of nutrition in the future.
